Indias Most Advanced Anonymous Search Engine, No tracking, We dont track you. Protect Your Privacy ,Local Web Search Engine

Search result for: Vioxx Lawsuit
Page: 1 2 3 4
Vioxx Lawsuit | Settlements, Injury Claims & Notable Cases
Vioxx, which Merck pulled from the market in 2004, was what’s known as a COX-2 inhibitor. It works by selectively targeting a specific enzyme that causes inflammation and pain, but it leaves other enzymes that protect the stomach and intestinal lining untouched.
Rofecoxib - Wikipedia
Rofecoxib is a selective COX-2 inhibitor, or "coxib". Though the class of coxibs includes several agents, there are varying degrees of COX-2 selectivity among them, with celecoxib (Celebrex) being the least COX-2 selective, and rofecoxib (Vioxx), valdecoxib (Bextra), and etoricoxib (Arcoxia), being highly COX-2 selective.
Vioxx Lawsuits | Recall Report
Vioxx Class Action Lawsuit. The biggest Vioxx lawsuit was a class action that represented thousands of people who died from a heart attack or stroke while taking Vioxx. Merck fought the accusations and never admitted to any wrongdoing, but ultimately agreed to a $4.85 billion settlement to be split among the families of those whose loved ones died.
Merck reaches $830M settlement in long-running Vioxx ...
Merck is closing a chapter in its seemingly never-ending saga for its painkiller Vioxx, agreeing to pay more than $800 million to settle a lawsuit over the med years after the company pulled its ...
Vioxx Lawsuit - $4.85 Billion Settlement - Heart Attack Risk
Vioxx Lawsuit – $4.85 Billion Settlement – Heart Attack Risk. Free Case Evaluation. Vioxx (rofecoxib) is a COX-2 inhibitor anti-inflammatory medication which was used as a pain reliever for disorders such as arthritis. Vioxx and several other COX-2 inhibitors were discontinued due to serious side effects caused by the drugs.
Vioxx Lawsuit - Product Liability |
This Vioxx lawsuit did not relate to Vioxx side effects, but rather, illegal promotion. Additionally, fines were placed on the company for concealing knowledge of serious Vioxx side effects. Because the bulk of Vioxx lawsuits has either been settled or dismissed, it will be difficult—at this time-- to secure compensation for a newly-filed ...
Merck Agrees to Settle Vioxx Suits for $4.85 Billion - The ...
Three years after withdrawing its pain medication Vioxx from the market, Merck has agreed to pay $4.85 billion to settle 27,000 lawsuits by people who claim they or their family members suffered ...
Merck settles Vioxx lawsuits for $4.85 billion : Nature News
Three years after it pulled its blockbuster painkiller Vioxx from the market, Merck has agreed to pay $4.85 billion to settle nearly 27,000 lawsuits that claim the arthritis drug caused heart ...
Vioxx Patient Injury Class Action Lawsuit
Vioxx Patient Injury Class Action Lawsuit. Result: $4.85 billion settlement Year: 2007. In re Vioxx Products Liability Litigation, MDL No. 1657 (E.D. La.). Lieff Cabraser represented patients that suffered heart attacks or strokes, and the families of loved ones who died, after having being prescribed the arthritis and pain medication Vioxx.
Merck loses third Vioxx lawsuit -
Orthopedics Today | A Texas jury ordered Merck & Co., maker of the painkiller Vioxx, to pay $32 million in damages to the family of a man who died of a heart attack. The plaintiffs alleged that ...
Merck to Pay $830 Million to Settle Vioxx Shareholder Suit ...
Merck agreed to pay more than $830 million to settle a lawsuit filed by shareholders who argued that the company had misled them by downplaying data regarding the former painkiller Vioxx.
Merck agrees to pay $830 million to settle Vioxx ...
U.S. drugmaker Merck & Co on Friday said it would pay $830 million to settle a federal class action lawsuit involving ... Merck agrees to pay $830 million to settle Vioxx securities lawsuit.
Vioxx Recalls | Recall Report
Vioxx, a once popular painkiller for conditions characterized by chronic pain, was fully recalled in 2004.It has not been on the market since, and although it was a voluntary recall by manufacturer Merck, the drug was bound to be pulled eventually whether through the company or the U.S. Food and Drug Administration.
Vioxx | Treatment for Arthritis & Recall for Patient Deaths
When Vioxx (rofecoxib) received its FDA approval in 1999, it was the second drug of its kind in a relatively new class of painkiller drugs called selective NSAIDs, or nonsteroidal anti-inflammatory drugs. This new class of NSAIDs, also referred to as COX-2 inhibitors, was claimed to have fewer gastrointestinal side effects than older nonselective NSAIDs like ibuprofen.
Merck settles class-action case over Vioxx for $830M - CBS ...
Merck will pay $830 million to resolve a federal class-action lawsuit involving shareholders and the painkiller Vioxx, which the drugmaker pulled from the market years ago over safety concerns.
Vioxx Lawsuit | Historic $4.65 Billion Settlement ...
Merck agreed to pay $4.85 billion, the largest pharmaceutical settlement in history, to resolve Vioxx-related claims involving plaintiffs who suffered a heart attack (including sudden cardiac death) or a stroke. Beasley Allen's team of Vioxx lawyers played an integral role in Merck agreeing to the record settlement.

Page: 1 2 3 4
Sponsored links :
Related result :
Copyright McClean Inc © 1995 -2019 - Email us : [email protected]
Powered By McCleaninc Search Technologies